by The pharmaceutical water market size is expected to reach USD 50.7 billion by 2030. It is anticipated to grow with a healthy CAGR of 9.86% from 2021 to 2030.
In 2022, the pharmaceutical water market study provides crucial information on market share, market size, growth rate analysis Y-O-Y, production, consumption, and sales analysis for the forecast period 2021 to 2030. The report contains 150+ pages with detailed analysis.
Water is the one of the foremost commodities utilized by the pharmaceutical sector. Water is extensively employed as vital ingredient, raw material, or solvent in the formulation, processing, and manufacture of active pharmaceutical ingredients, pharmaceutical products, and intermediates, analytical reagents and compendial articles. It might present as an excipient, or employed during synthesis, reconstitution of products, throughout production of finished product, cleaning agent for washing vessels, and primary packing materials among others. There are numerous different grades of water utilized for pharmaceutical purposes. There are numerous particular kinds of packaged waters, differing in their elected applications, packaging limits, and other quality characteristics.
The high demand for steady water supply has forced manufacturers in the pharmaceutical water industry to implement water recycle practices. Water reuse is safeguarding sustainability of water resources and is refining water effectiveness in the value chain. Service providers are providing commission, installation, and validation of purification systems to pharmaceutical customers. Inventions in these systems are fetching prominence in European nations where local manufacturers are firming their global distribution chains.
Growth Factors
Manufacturing of medicines need high-purity water in the manufacture process and the waste water stream can be profoundly laden with contaminants, toxins and organic nutrients which requires to be treated beforehand disposal, necessitating water and waste water treatment equipment. Development of the biopharmaceutical sector can be credited to large unmet medical requirements in the dealing chronic medical circumstances, patent expiry of patented biologic drugs that leads growth of biosimilar drugs, and a great number of clinical pipeline drugs. Furthermore, swift expansion of the vaccines sector is expected to push the biopharmaceutical industry in the near future. Hence, demand for pharmaceutical water is likely to rise, along with the development of the biopharmaceutical and generic injectable sectors throughout the estimate period.
High surge in burden of diabetes amongst the aged and obese populace around the globe is a major influence probable to push the global pharmaceutical water market throughout the prediction period. The pharmaceutical water market in Asia Pacific is expected to advance at a rapid rate throughout the prediction period. Growth of pharmaceutical water and other pharma products to manage with ailments and intensification in responsiveness leading to routine checkup and verdict are the main influences estimated to boost the growth of pharmaceutical water market in Asia Pacific.
Market Scope:
| Report Highlights | Details |
| Market Size | USD 50.7 Billion by 2027 |
| Growth Rate | CAGR of 9.86% from 2021 to 2027 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2027 |
| Segments Covered | Type, Application, Region |
COVID-19 Impact:
The industrial report mentions the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The pharmaceutical water report proficiently explains the resulting factors and concerns of manufacturers. Researchers have also well-explained how the producers and providers will tackle the ongoing epidemic and the key strategies to be adopted post-pandemic for turning their businesses back to normal.
Regional Snapshots
The established economies of the U.S., Western Europe and Japan presently signify half of all expenditure in the global water for pharmaceuticals market. These nations are predicted to endure the largest markets for water technologies in this business over coming years.
Europe is the second largest pharmaceutical manufacturing markets and has appeared as a very profitable high value opening to stake holders in the water sector. Some of the principal companies have made noteworthy investments on research and development and also placing themselves as providers of professional solutions for the pharmaceutical industry. These funds are channeled to augment ground-breaking water and wastewater treatment solutions, examine and progress prevailing technologies to address the existing and anticipated fluctuations to the European Pharmacopoeia’s water standards.
In Japan, the growth in expenditure on water for pharma is anticipated to be higher, at about 4% annually. The governments is endorsing the augmented application of generic drugs, permitting for prolonged production capacities. In addition, best pricing guarantee restructurings will also go some way to easing the impacts of the patent cliff.
Key Players:
The pharmaceutical water market is consolidated with a major number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.
Some of the prominent players in the pharmaceutical water market include:
- Baxter International, Inc.
- Merck KGaA
- Braun Melsungen AG
- Thermo Fisher Scientific, Inc
- Cytiva (Danaher)
- Fresenius Kabi AG
- Pfizer, Inc.
- CovaChem, LLC
- Intermountain Life Sciences
Market Segmentation
By Type
- HPLC Grade Water
- Water for Injection
By Application
- Pharmaceutical & Biotechnology Companies
- Academics & Research Laboratories
Regional Segmentation
- North America (U.S. and Canada)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Find More Press Releases at https://www.globenewswire.com/en/search/organization/Precedence%2520Research
Frequently Asked Questions?
- What is the total market value?
- What will be the growth in 2030?
- What are the key trends in the market?
- What are the major players in pharmaceutical water markets?
- What are the key growth strategies of industry players?
- Which region would offer a higher growth?
- What are the countries included in the rest of the word segments?
- How can I get report sample?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Pharmaceutical Water Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Pharmaceutical Water Market
5.1. Covid-19: Pharmaceutical Water Industry Impact
5.2. Pharmaceutical Water Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pharmaceutical Water Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pharmaceutical Water Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Pharmaceutical Water Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
Chapter 7. Global Pharmaceutical Water Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pharmaceutical Water Market Revenue by Market Players (2015-2020)
7.1.1.2. Pharmaceutical Water Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Pharmaceutical Water Market, By Product Type
8.1. Pharmaceutical Water Market, by Product Type, 2016-2027
8.1.1. HPLC Grade Water
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Water for Injection
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Pharmaceutical Water Market, By Application
9.1. Pharmaceutical Water Market, by Application, 2016-2027
9.1.1. Pharmaceutical & Biotechnology Companies
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Academics & Research Laboratories
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Pharmaceutical Water Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by Application (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type(2016-2027)
10.2.2. Market Revenue Forecast by Application (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type(2016-2027)
10.3.2. Market Revenue Forecast by Application (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type(2016-2027)
10.4.2. Market Revenue Forecast by Application (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type(2016-2027)
10.5.2. Market Revenue Forecast by Application (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)
Chapter 11. Company Profiles
11.1. Baxter International, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Merck KGaA
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. B. Braun Melsungen AG
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. Thermo Fisher Scientific, Inc
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. Cytiva (Danaher)
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Fresenius Kabi AG
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Pfizer, Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. CovaChem, LLC
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Intermountain Life Sciences
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Standard Reagents, Pvt. Ltd
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
